INGRAM DOUGLAS S — SEC Form 4 filings

SEC reporting owner CIK 1190644. 6 Form 4 filings on record with FilingPulse; latest filed 2026-06-10.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-06-05 to 2026-06-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Sarepta Therapeutics, Inc. (SRPT)Chief Executive Officer, Director15
Relay Therapeutics, Inc. (RLAY)Director33
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Director22

Form 4 filings — INGRAM DOUGLAS S

FiledFormIssuerReported transactionsSource
2026-06-104Relay Therapeutics, Inc. (RLAY)Grant/award (A): 32,947 (derivative) @ $0EDGAR
2025-12-184ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Grant/award (A): 7,819 @ $0EDGAR
2025-12-094Sarepta Therapeutics, Inc. (SRPT)Grant/award (A): 50,000 @ $0 · Grant/award (A): 50,000 @ $0 · Grant/award (A): 73,001 @ $0 · Grant/award (A): 96,541 @ $0 · Grant/award (A): 269,542 @ $0EDGAR
2025-06-064Relay Therapeutics, Inc. (RLAY)Grant/award (A): 136,681 (derivative) @ $0EDGAR
2025-02-074ARROWHEAD PHARMACEUTICALS, INC. (ARWR)Grant/award (A): 38,396 @ $20.09EDGAR
2024-06-054Relay Therapeutics, Inc. (RLAY)Grant/award (A): 102,225 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1190644 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →